Cargando…

Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain

The objective of this study was to assess current treatment patterns, blood glucose test strip usage, and treatment compliance in patients with type 2 diabetes mellitus (T2DM) in primary care centers in Spain, and to assess factors related to glycemic control. We conducted a retrospective chart revi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yurgin, Nicole Rae, Boye, Kristina Secnik, Dilla, Tatiana, Suriñach, Núria Lara, Llach, Xavier Badia
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770414/ https://www.ncbi.nlm.nih.gov/pubmed/19920948

Ejemplares similares

Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001
por: Johnson, Jeffrey A, et al.
Publicado: (2006)

Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
por: Matza, Louis S, et al.
Publicado: (2007)

Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes
por: Shetty, Sharashchandra, et al.
Publicado: (2005)

Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes
por: Valentine, William, et al.
Publicado: (2022)

The association between diabetes related medical costs and glycemic control: A retrospective analysis
por: Oglesby, Alan K, et al.
Publicado: (2006)

Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review
por: Núñez, Mercedes, et al.
Publicado: (2019)

Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments
por: Poulos, Christine, et al.
Publicado: (2013)

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain
por: Costi , María, et al.
Publicado: (2009)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
por: Hong, Jihyung, et al.
Publicado: (2009)

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
por: Dilla, Tatiana, et al.
Publicado: (2012)

Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database
por: Boye, Kristina Secnik, et al.
Publicado: (2016)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
por: Johansson, Erin, et al.
Publicado: (2018)

Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain
por: Diez-Domingo, Javier, et al.
Publicado: (2010)

Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
por: Alghadeer, Sultan M., et al.
Publicado: (2021)

Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
por: Secnik Boye, Kristina, et al.
Publicado: (2006)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Physician Perceptions of the Use of Medications for Attention Deficit Hyperactivity Disorder
por: Stockl, Karen M., et al.
Publicado: (2003)

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
por: Schweikert, Bernd, et al.
Publicado: (2020)

Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
por: Miñambres, I., et al.
Publicado: (2016)

Clinical audit on assessment of non-glycemic parameters in diabetic patients by physicians
por: Ramya, S, et al.
Publicado: (2021)

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
por: Dilla, Tatiana, et al.
Publicado: (2014)

Development, Implementation, and Evaluation of a Physician-Targeted Inpatient Glycemic Management Curriculum
por: Mathioudakis, Nestoras, et al.
Publicado: (2019)

Family Physician Clinical Inertia in Glycemic Control among Patients with Type 2 Diabetes
por: Lang, Valerija Bralić, et al.
Publicado: (2015)

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
por: Badia, Xavier, et al.
Publicado: (2020)

Observational study evaluating the effectiveness of physician‐targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II)
por: Weng, Jianping, et al.
Publicado: (2019)

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
por: Fu, Haoda, et al.
Publicado: (2015)

Acromegaly Quality of Life Questionnaire (AcroQoL)
por: Badia, Xavier, et al.
Publicado: (2004)

Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain)
por: Gimenez-Perez, Gabriel, et al.
Publicado: (2021)

Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
por: Fu, Haoda, et al.
Publicado: (2015)

Glycemic control and diabetes management in hospitalized patients in Brazil
por: Moreira Jr, Edson Duarte, et al.
Publicado: (2013)

The Role of Glycemic Index and Glycemic Load in the Development of Real-Time Postprandial Glycemic Response Prediction Models for Patients with Gestational Diabetes
por: Pustozerov, Evgenii, et al.
Publicado: (2020)

Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature
por: Sacristán, José Antonio, et al.
Publicado: (2020)

National physician survey on glycemic goals and medical decision making for patients with type 2 diabetes
por: Laiteerapong, Neda, et al.
Publicado: (2019)

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population
por: Asukai, Yumi, et al.
Publicado: (2010)

Airway management of COVID-19 patients: A survey on the experience of 1125 physicians in Spain()
por: Granell Gil, M., et al.
Publicado: (2022)

Perception of HIV physicians in Spain towards diagnosis and management of neuropsychiatric comorbidities in people with HIV
por: Pérez‐Valero, Ignacio, et al.
Publicado: (2022)

Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes
por: McCoy, Rozalina G, et al.
Publicado: (2020)

Standardized Glycemic Management versus Conventional Glycemic Management and Postoperative Outcomes in Type 2 Diabetes Patients Undergoing Elective Surgery
por: Vongsumran, Nuttawut, et al.
Publicado: (2020)

Health Literacy, Glycemic Control, and Physician-Advised Glucose Self-Monitoring Use in Type 2 Diabetes
por: Alvarez, Paul M., et al.
Publicado: (2018)

Managing Type 2 Diabetes: Going Beyond Glycemic Control
por: Stolar, Mark W., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k65nanda6lq3vvb88f13hav66q